Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Total 13F shares
-
5,962,979
-
Share change
-
-909,119
-
Total reported value
-
$32,576,856
-
Put/Call ratio
-
55%
-
Price per share
-
$5.04
-
Number of holders
-
36
-
Value change
-
-$4,921,316
-
Number of buys
-
17
-
Number of sells
-
21
Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q3 2021
As of 30 Sep 2021 Eton Pharmaceuticals, Inc. - Common Stock (ETON) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,962,979 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., VANGUARD GROUP INC, AWM Investment Company, Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Westside Investment Management, Inc., BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and GSA CAPITAL PARTNERS LLP.
This table shows 36 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.